Although these studies, combined with fundamental research into the role of GSK3α/β in viral replication, support a role for GSK3α/β in COVID-19, some studies report that the toxic levels of lithium required to inhibit coronavirus replication likely limits the potential of this widely used treatment (37, 39). Here, GSK3A is linked to COVID-19.